Sustained Improvements in Patient-Reported Quality of Life Up to 24 Months Post-Treatment with LentiGlobin for Sickle Cell Disease (bb1111) Gene Therapy
BLOOD(2021)
Key words
Sickle-cell Disease
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined